![]() Chugai Pharmaceutical Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases. | ![]() Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | ||
Founding Date | Founding Date 1925 | Founding Date 1982 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Chuo City, JP HQ Guangzhou Shi, CN Taizhou, CN Puteaux, FR Frankfurt Am Main, DE Singapore, SG see more | Locations Morris Plains, US HQ | Locations TW HQ San Mateo, US |
Employees | Employees 7,778 | Employees 8914% decrease | Employees 514% increase |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.3t (FY, 2025) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥363.7b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥903.5b (FY, 2025) | Gross profit $295k (FY, 2019) | Gross profit N/A |
Net income | Net income ¥434b (FY, 2025) | Net income ($357.3m) (FY, 2019) | Net income N/A |

Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View companyAcepodia is a biotech company developing cell therapies for cancer.
View company